Health : Medical Research (Grantmaking)

Foundation for Angelman Syndrome Therapeutics

Cure Angelman Now.

three stars

89.24

P.O. Box 608 Downers Grove, IL 60515
tel: (630) 852-3278   Web Site
EIN: 26-3160079

Board Leadership
Paula M. Evans
Chairperson

CEO
Paula M. Evans
Chairperson

  Score
(out of 100)
Rating
Overall Score & Rating 89.24 three stars
  Financial 97.50 four stars
  Accountability & Transparency 85.00 three stars
This rating was published 08/01/2019 and includes data from FY2017, the most recent 990 received at that time.

The Foundation for Angelman Syndrome Therapeutics (FAST) is committed to accelerating treatments and a cure for Angelman syndrome (AS). The symptoms of AS have been under-addressed in the research community for far too long. Research aimed at identifying treatments for the motor dysfunction, seizures and behavioral characteristics of Angelman syndrome is one of FAST's top priorities. Our goal is to bring practical treatment into current medical practice as quickly as possible. It is our hope that grants we fund will lead to additional research support from government agencies, other funding sources and organizations around the globe.

The Foundation for Angelman Syndrome Therapeutics (FAST) is committed to accelerating treatments and a cure for Angelman syndrome (AS). The symptoms of AS have been under-addressed in the research community for far too long. Research aimed at identifying treatments for the motor dysfunction, seizures and behavioral characteristics of Angelman syndrome is one of FAST's top priorities. Our goal is to bring practical treatment into current medical practice as quickly as possible. It is our hope that grants we fund will lead to additional research support from government agencies, other funding sources and organizations around the globe.

Impact Information

Looking for Impact Information?

Charity Navigator is collaborating with GuideStar, GlobalGiving, Classy, and ImpactMatters to display impact-related information for rated nonprofits. However, not all rated nonprofits have provided impact information yet. Each of these partners has supplied Charity Navigator with the impact information they receive directly from nonprofits. Submissions must be made on our partner's websites and we plan to update the display of this information regularly.

If you are interested in seeing this charity provide its impact information, please click below. Note, this is simply an indication of your interest.

Financial

four stars

97.50

Accountability & Transparency

three stars

85.00

This rating was published 08/01/2019 and includes data from FY2017, the most recent 990 received at that time.
Overall Rating Chart
  Program Expenses
(Percent of the charity's total expenses spent on the programs
and services it delivers)
94.1%
  Administrative Expenses 2.2%
  Fundraising Expenses 3.5%
  Fundraising Efficiency $0.02
  Working Capital Ratio (years) 1.51
  Program Expenses Growth 67.7%
  Liabilities to Assets 31.9%
All data for Financial Performance Metrics calculations was provided by Foundation for Angelman Syndrome Therapeutics on recent 990s filed with the IRS.
All data for Financial Performance Metrics calculations was provided by Foundation for Angelman Syndrome Therapeutics on recent 990s filed with the IRS.
REVENUE  
Contributions  
   Contributions, Gifts & Grants $5,356,247
   Federated Campaigns $0
   Membership Dues $0
   Fundraising Events $3,433,755
   Related Organizations $0
   Government Grants $0
Total Contributions $8,790,002
   Program Service Revenue $0
Total Primary Revenue $8,790,002
   Other Revenue $-40,303
TOTAL REVENUE $8,749,699
   
EXPENSES  
   Program Expenses $5,450,858
   Administrative Expenses $98,006
   Fundraising Expenses $94,966
TOTAL FUNCTIONAL EXPENSES $5,643,830
   
Payments to Affiliates $0
Excess (or Deficit) for the year $3,105,869
   
Net Assets $5,247,408

Charts

Compensation % of Expenses Paid to Title
Not compensated -- Paula Evans Chairperson

Mission

The Foundation for Angelman Syndrome Therapeutics (FAST) is committed to accelerating treatments and a cure for Angelman syndrome (AS). The symptoms of AS have been under-addressed in the research community for far too long. Research aimed at identifying treatments for the motor dysfunction, seizures and behavioral characteristics of Angelman syndrome is one of FAST's top priorities. Our goal is to bring practical treatment into current medical practice as quickly as possible. It is our hope that grants we fund will lead to additional research support from government agencies, other funding sources and organizations around the globe.

Highly Rated

Charity Name & State Overall Score Overall Rating
Foundation for Angelman Syndrome Therapeutics (IL) 89.24 three stars
Retina Foundation of the Southwest (TX) 92.62 four stars
CDC Foundation (GA) 98.23 four stars
Midwest Athletes Against Childhood Cancer (WI) 95.07 four stars
American Committee for the Weizmann Institute of Science (NY) 95.03 four stars

Compare These Charities (Highly Rated)

Charity Contact Info

Foundation for Angelman Syndrome Therapeutics
P.O. Box 608
Downers Grove, IL 60515
tel: (630) 852-3278
fax: (630) 852-3270
EIN: 26-3160079

Visit Web Site

Board Leadership

Paula M. Evans
Chairperson

CEO

Paula M. Evans
Chairperson